Breaking News Instant updates and real-time market news.

BCS

Barclays

$10.09 /

-0.01 (-0.10%)

06:12
03/16/21
03/16
06:12
03/16/21
06:12

Barclays upgraded to Outperform from Neutral at Credit Suisse

Credit Suisse analyst Omar Keenan upgraded Barclays to Outperform from Neutral with a price target of 210 GBp, up from 155 GBp, after assuming coverage of the name. The analyst sees U.K. domestic banks at a "cyclical and even structural turning point post lockdowns." Consensus U.K. bank return expectations look too low in a G20 context, Keenan tells investors in a research note.

  • 23

    Mar

BCS Barclays
$10.09 /

-0.01 (-0.10%)

03/11/21 Goldman Sachs
Barclays upgraded to Buy from Neutral at Goldman Sachs
03/05/21 AlphaValue/Baader
Barclays upgraded to Add from Sell at AlphaValue
02/23/21 JPMorgan
Barclays price target raised to 190 GBp from 180 GBp at JPMorgan
02/22/21 RBC Capital
Barclays price target raised to 150 GBp from 140 GBp at RBC Capital

TODAY'S FREE FLY STORIES

Hot Stocks
International Paper says GHG reduction target approved by SBTi » 07:32
12/03/21
12/03
07:32
12/03/21
07:32
IP

International Paper

$45.89 /

+0.72 (+1.59%)

The company stated,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IP International Paper
$45.89 /

+0.72 (+1.59%)

IP International Paper
$45.89 /

+0.72 (+1.59%)

11/23/21 Deutsche Bank
International Paper named 'catalyst call sell' at Deutsche Bank
11/08/21 KeyBanc
International Paper price target lowered to $44 from $50 at KeyBanc
11/01/21 Jefferies
International Paper downgraded to Hold at Jefferies on 'challenging setup'
11/01/21 Jefferies
International Paper downgraded to Hold from Buy at Jefferies
IP International Paper
$45.89 /

+0.72 (+1.59%)

IP International Paper
$45.89 /

+0.72 (+1.59%)

IP International Paper
$45.89 /

+0.72 (+1.59%)

Hot Stocks
Zai Lab announces inclusion of ZEJULA in China's NRDL for ovarian cancer » 07:32
12/03/21
12/03
07:32
12/03/21
07:32
ZLAB

Zai Lab

$71.31 /

-0.17 (-0.24%)

Zai Lab announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ZLAB Zai Lab
$71.31 /

-0.17 (-0.24%)

ZLAB Zai Lab
$71.31 /

-0.17 (-0.24%)

10/12/21 Bernstein
Zai Lab initiated with a Market Perform at Bernstein
04/14/21 SVB Leerink
Zai Lab price target raised to $192 from $183 at SVB Leerink
04/13/21 Goldman Sachs
Zai Lab price target raised to $211.23 after LUNAR trial update at Goldman Sachs
04/13/21 Guggenheim
Zai Lab price target raised to $250 from $165 at Guggenheim
ZLAB Zai Lab
$71.31 /

-0.17 (-0.24%)

  • 21
    Apr
Downgrade
DocuSign downgraded to Hold at Needham on faster slowdown in demand » 07:31
12/03/21
12/03
07:31
12/03/21
07:31
DOCU

DocuSign

$233.83 /

+2.77 (+1.20%)

Needham analyst Scott…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DOCU DocuSign
$233.83 /

+2.77 (+1.20%)

DOCU DocuSign
$233.83 /

+2.77 (+1.20%)

07:18 Today Needham
DocuSign downgraded to Hold from Buy at Needham
07:08 Today Baird
DocuSign price target lowered to $220 from $330 at Baird
06:36 Today Wedbush
DocuSign downgraded to Neutral from Outperform at Wedbush
06:36 Today JMP Securities
DocuSign price target lowered to $307 from $320 at JMP Securities
DOCU DocuSign
$233.83 /

+2.77 (+1.20%)

DOCU DocuSign
$233.83 /

+2.77 (+1.20%)

DOCU DocuSign
$233.83 /

+2.77 (+1.20%)

DOCU DocuSign
$233.83 /

+2.77 (+1.20%)

Initiation
Riot Blockchain initiated with a Buy at Roth Capital » 07:31
12/03/21
12/03
07:31
12/03/21
07:31
RIOT

Riot Blockchain

$32.95 /

-2.77 (-7.75%)

Roth Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RIOT Riot Blockchain
$32.95 /

-2.77 (-7.75%)

RIOT Riot Blockchain
$32.95 /

-2.77 (-7.75%)

11/16/21 BTIG
Riot Blockchain price target raised to $50 from $45 at BTIG
10/28/21 PI Financial
Sphere 3D initiated with a Buy at PI Financial
10/14/21 DA Davidson
Riot Blockchain initiated with a Buy at DA Davidson
10/14/21 DA Davidson
Riot Blockchain initiated with a Buy at DA Davidson
RIOT Riot Blockchain
$32.95 /

-2.77 (-7.75%)

RIOT Riot Blockchain
$32.95 /

-2.77 (-7.75%)

RIOT Riot Blockchain
$32.95 /

-2.77 (-7.75%)

RIOT Riot Blockchain
$32.95 /

-2.77 (-7.75%)

Recommendations
Marvell price target raised to $100 from $85 at JPMorgan » 07:30
12/03/21
12/03
07:30
12/03/21
07:30
MRVL

Marvell

$71.02 /

+0.18 (+0.25%)

JPMorgan analyst Harlan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MRVL Marvell
$71.02 /

+0.18 (+0.25%)

MRVL Marvell
$71.02 /

+0.18 (+0.25%)

07:14 Today BMO Capital
Marvell price target raised to $98 from $85 at BMO Capital
07:10 Today Goldman Sachs
Goldman admits to being wrong to stay on sidelines, upgrades Marvell to Buy
07:06 Today Goldman Sachs
Marvell upgraded to Buy from Neutral at Goldman Sachs
06:49 Today UBS
Marvell price target raised to $95 from $87 at UBS
MRVL Marvell
$71.02 /

+0.18 (+0.25%)

MRVL Marvell
$71.02 /

+0.18 (+0.25%)

MRVL Marvell
$71.02 /

+0.18 (+0.25%)

MRVL Marvell
$71.02 /

+0.18 (+0.25%)

Options
Unusual put flow in option market yesterday » 07:30
12/03/21
12/03
07:30
12/03/21
07:30
RUN

Sunrun

$42.33 /

-0.45 (-1.05%)

Notable put activity was…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RUN Sunrun
$42.33 /

-0.45 (-1.05%)

RUN Sunrun
$42.33 /

-0.45 (-1.05%)

12/02/21 JPMorgan
Concerns over California net metering program overblown, says JPMorgan
11/15/21 Roth Capital
Roth Capital not expecting A-SMACC to reveal petitioner to keep anti-circ case alive
11/11/21 Morgan Stanley
Commerce rejection negative for First Solar, Maxeon, says Morgan Stanley
11/10/21 Roth Capital
Anti-Circ thrown out, incremental negative for First Solar, says Roth Capital
RUN Sunrun
$42.33 /

-0.45 (-1.05%)

RUN Sunrun
$42.33 /

-0.45 (-1.05%)

RUN Sunrun
$42.33 /

-0.45 (-1.05%)

Recommendations
Allogene Therapeutics clinical hold could be lifted shortly, says Canaccord » 07:29
12/03/21
12/03
07:29
12/03/21
07:29
ALLO

Allogene Therapeutics

$19.07 /

+0.82 (+4.49%)

Canaccord analyst John…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ALLO Allogene Therapeutics
$19.07 /

+0.82 (+4.49%)

ALLO Allogene Therapeutics
$19.07 /

+0.82 (+4.49%)

10/19/21 Cowen
Allogene Therapeutics assumed with an Outperform at Cowen
10/12/21 JMP Securities
Allogene Therapeutics price target lowered to $27 from $53 at JMP Securities
10/08/21
Fly Intel: Top five analyst downgrades
10/08/21 Jefferies
Jefferies lowers Allogene price target to $30, says 'buy this dip'
ALLO Allogene Therapeutics
$19.07 /

+0.82 (+4.49%)

ALLO Allogene Therapeutics
$19.07 /

+0.82 (+4.49%)

ALLO Allogene Therapeutics
$19.07 /

+0.82 (+4.49%)

Recommendations
TransDigm price target raised to $670 from $665 at JPMorgan » 07:28
12/03/21
12/03
07:28
12/03/21
07:28
TDG

TransDigm

$581.57 /

+28.105 (+5.08%)

JPMorgan analyst Seth…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TDG TransDigm
$581.57 /

+28.105 (+5.08%)

TDG TransDigm
$581.57 /

+28.105 (+5.08%)

11/23/21
Fly Intel: Top five analyst upgrades
11/23/21 BofA
TransDigm upgraded to Buy at BofA ahead of commercial aerospace recovery
11/23/21 BofA
TransDigm upgraded to Buy from Neutral at BofA
11/22/21 Baird
TransDigm price target raised to $720 from $668 at Baird
TDG TransDigm
$581.57 /

+28.105 (+5.08%)

TDG TransDigm
$581.57 /

+28.105 (+5.08%)

Recommendations
JPMorgan 'constructive' on FedEx shares into Q2 results » 07:27
12/03/21
12/03
07:27
12/03/21
07:27
FDX

FedEx

$235.39 /

+7.655 (+3.36%)

, UPS

UPS

$199.99 /

+5.77 (+2.97%)

JPMorgan analyst Brian…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FDX FedEx
$235.39 /

+7.655 (+3.36%)

UPS UPS
$199.99 /

+5.77 (+2.97%)

FDX FedEx
$235.39 /

+7.655 (+3.36%)

11/29/21 Deutsche Bank
Deutsche Bank downgrades UPS to Hold, now prefers FedEx
11/09/21 Deutsche Bank
FedEx named short-term buy idea at Deutsche Bank
10/08/21 Citi
FedEx earnings estimates cut below guidance at Citi
10/06/21 Cowen
FedEx price target lowered to $283 from $297 at Cowen
UPS UPS
$199.99 /

+5.77 (+2.97%)

11/29/21
Fly Intel: Top five analyst downgrades
11/29/21 Deutsche Bank
Deutsche Bank downgrades UPS to Hold, now prefers FedEx
11/29/21 Deutsche Bank
UPS downgraded to Hold from Buy at Deutsche Bank
10/27/21
Fly Intel: Top five analyst downgrades
FDX FedEx
$235.39 /

+7.655 (+3.36%)

UPS UPS
$199.99 /

+5.77 (+2.97%)

FDX FedEx
$235.39 /

+7.655 (+3.36%)

UPS UPS
$199.99 /

+5.77 (+2.97%)

FDX FedEx
$235.39 /

+7.655 (+3.36%)

UPS UPS
$199.99 /

+5.77 (+2.97%)

FDX FedEx
$235.39 /

+7.655 (+3.36%)

UPS UPS
$199.99 /

+5.77 (+2.97%)

Recommendations
Sellas Life Sciences price target lowered to $16 from $18 at Cantor Fitzgerald » 07:27
12/03/21
12/03
07:27
12/03/21
07:27
SLS

Sellas Life Sciences

$6.42 /

+0.08 (+1.26%)

Cantor Fitzgerald analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SLS Sellas Life Sciences
$6.42 /

+0.08 (+1.26%)

SLS Sellas Life Sciences
$6.42 /

+0.08 (+1.26%)

07/21/21 Cantor Fitzgerald
Sellas Life Sciences initiated with an Overweight at Cantor Fitzgerald
07/21/21 Cantor Fitzgerald
Sellas Life Sciences initiated with an Overweight at Cantor Fitzgerald
06/25/21 Maxim
Sellas Life Sciences price target raised to $21 from $12 at Maxim
06/03/21 Alliance Global Partners
Sellas Life Sciences price target raised to $16.50 from $8 at Alliance Global Partners
SLS Sellas Life Sciences
$6.42 /

+0.08 (+1.26%)

Periodicals
Credit Suisse plans to restructure banker pay, Bloomberg reports » 07:25
12/03/21
12/03
07:25
12/03/21
07:25
CS

Credit Suisse

$9.72 /

+0.22 (+2.32%)

Credit Suisse chairman…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CS Credit Suisse
$9.72 /

+0.22 (+2.32%)

CS Credit Suisse
$9.72 /

+0.22 (+2.32%)

11/16/21 JPMorgan
Credit Suisse downgraded to Underweight on new strategy at JPMorgan
11/16/21 JPMorgan
Credit Suisse downgraded to Underweight from Neutral at JPMorgan
11/15/21 Morgan Stanley
Credit Suisse price target raised to CHF 12 from CHF 11 at Morgan Stanley
11/09/21 Keefe Bruyette
Credit Suisse downgraded to Market Perform from Outperform at Keefe Bruyette
CS Credit Suisse
$9.72 /

+0.22 (+2.32%)

CS Credit Suisse
$9.72 /

+0.22 (+2.32%)

CS Credit Suisse
$9.72 /

+0.22 (+2.32%)

CS Credit Suisse
$9.72 /

+0.22 (+2.32%)

Upgrade
Tisco Financial upgraded to Overweight from Neutral at JPMorgan » 07:25
12/03/21
12/03
07:25
12/03/21
07:25
TICSF

Tisco Financial

/

+

JPMorgan analyst Harsh…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Conference/Events
UBS technology analysts to hold an analyst/industry conference call » 07:25
12/03/21
12/03
07:25
12/03/21
07:25
MRVL

Marvell

$71.02 /

+0.18 (+0.25%)

Technology Analysts…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MRVL Marvell
$71.02 /

+0.18 (+0.25%)

MRVL Marvell
$71.02 /

+0.18 (+0.25%)

07:14 Today BMO Capital
Marvell price target raised to $98 from $85 at BMO Capital
07:10 Today Goldman Sachs
Goldman admits to being wrong to stay on sidelines, upgrades Marvell to Buy
07:06 Today Goldman Sachs
Marvell upgraded to Buy from Neutral at Goldman Sachs
06:49 Today UBS
Marvell price target raised to $95 from $87 at UBS
MRVL Marvell
$71.02 /

+0.18 (+0.25%)

MRVL Marvell
$71.02 /

+0.18 (+0.25%)

MRVL Marvell
$71.02 /

+0.18 (+0.25%)

MRVL Marvell
$71.02 /

+0.18 (+0.25%)

Recommendations
Toronto-Dominion price target raised to C$102.50 from C$96.50 at Canaccord » 07:24
12/03/21
12/03
07:24
12/03/21
07:24
TD

Toronto-Dominion

$75.33 /

+3.58 (+4.99%)

Canaccord analyst Scott…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TD Toronto-Dominion
$75.33 /

+3.58 (+4.99%)

TD Toronto-Dominion
$75.33 /

+3.58 (+4.99%)

11/23/21 Scotiabank
Toronto-Dominion price target raised to C$104 from C$94 at Scotiabank
11/22/21 BofA
BofA lists three reasons to double upgrade Toronto-Dominion to Buy
11/22/21 BofA
Toronto-Dominion upgraded to Buy from Underperform at BofA
10/01/21 National Bank
Toronto-Dominion upgraded to Outperform from Sector Perform at National Bank
TD Toronto-Dominion
$75.33 /

+3.58 (+4.99%)

TD Toronto-Dominion
$75.33 /

+3.58 (+4.99%)

TD Toronto-Dominion
$75.33 /

+3.58 (+4.99%)

Upgrade
Singapore Exchange upgraded to Overweight from Neutral at JPMorgan » 07:24
12/03/21
12/03
07:24
12/03/21
07:24
SPXCF

Singapore Exchange

$6.60 /

-0.02 (-0.30%)

JPMorgan analyst Harsh…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SPXCF Singapore Exchange
$6.60 /

-0.02 (-0.30%)

08/24/21 Credit Suisse
Singapore Exchange downgraded to Underperform from Neutral at Credit Suisse
08/22/21 Goldman Sachs
Singapore Exchange downgraded to Neutral from Buy at Goldman Sachs
Upgrade
OCBC upgraded to Overweight from Neutral at JPMorgan » 07:23
12/03/21
12/03
07:23
12/03/21
07:23
OVCHY

OCBC

$16.49 /

+0.25 (+1.54%)

JPMorgan analyst Harsh…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OVCHY OCBC
$16.49 /

+0.25 (+1.54%)

04/06/21 Goldman Sachs
OCBC upgraded to Buy from Neutral at Goldman Sachs
03/10/21 JPMorgan
OCBC upgraded to Overweight from Neutral at JPMorgan
Initiation
International Container Terminal initiated with an Overweight at JPMorgan » 07:22
12/03/21
12/03
07:22
12/03/21
07:22
ICTEF

International Container Terminal Services

$3.90 /

+ (+0.00%)

JPMorgan analyst Shawn Ng…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Initiation
Cardiol Therapeutics initiated with a Buy at Canaccord » 07:22
12/03/21
12/03
07:22
12/03/21
07:22
CRDL

Cardiol Therapeutics

$2.02 /

+0.155 (+8.33%)

Canaccord analyst Edward…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CRDL Cardiol Therapeutics
$2.02 /

+0.155 (+8.33%)

CRDL Cardiol Therapeutics
$2.02 /

+0.155 (+8.33%)

08/25/21 Raymond James
Cardiol Therapeutics price target raised to C$5 from C$4.50 at Raymond James
08/24/21 Raymond James
Raymond James ups Cardiol target to C$5 after FDA clears Phase II study
  • 03
    Nov
CRDL Cardiol Therapeutics
$2.02 /

+0.155 (+8.33%)

CRDL Cardiol Therapeutics
$2.02 /

+0.155 (+8.33%)

CRDL Cardiol Therapeutics
$2.02 /

+0.155 (+8.33%)

Recommendations
Citi opens 'positive catalyst watch' on Stellantis into software day » 07:21
12/03/21
12/03
07:21
12/03/21
07:21
STLA

Stellantis

$18.15 /

+0.455 (+2.57%)

Citi analyst Gabriel…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
STLA Stellantis
$18.15 /

+0.455 (+2.57%)

STLA Stellantis
$18.15 /

+0.455 (+2.57%)

11/29/21 Citi
Stellantis resumed with a Buy at Citi
11/02/21 Nomura
Nomura downgrades Ford to Reduce, calls premium valuation 'hard to justify'
09/07/21 KeyBanc
Jeep micro site on Amazon points to auto sales moving online, says KeyBanc
09/03/21 Deutsche Bank
Stellantis deal 'significant opportunity' for Open Lending, says Deutsche Bank
STLA Stellantis
$18.15 /

+0.455 (+2.57%)

STLA Stellantis
$18.15 /

+0.455 (+2.57%)

STLA Stellantis
$18.15 /

+0.455 (+2.57%)

Downgrade
TopBuild downgraded to Neutral from Buy at BTIG » 07:19
12/03/21
12/03
07:19
12/03/21
07:19
BLD

TopBuild

$276.83 /

+12.445 (+4.71%)

BTIG analyst Ryan Gilbert…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BLD TopBuild
$276.83 /

+12.445 (+4.71%)

BLD TopBuild
$276.83 /

+12.445 (+4.71%)

11/03/21 Truist
TopBuild price target raised to $300 from $253 at Truist
10/21/21 BTIG
TopBuild price target raised to $292 from $271 at BTIG
09/10/21 JPMorgan
TopBuild price target raised to $264 from $246 at JPMorgan
09/09/21
Fly Intel: Top five analyst upgrades
BLD TopBuild
$276.83 /

+12.445 (+4.71%)

Downgrade
DocuSign downgraded to Hold from Buy at Needham » 07:18
12/03/21
12/03
07:18
12/03/21
07:18
DOCU

DocuSign

/

+

Needham analyst Scott…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DOCU DocuSign
/

+

DOCU DocuSign
/

+

07:08 Today Baird
DocuSign price target lowered to $220 from $330 at Baird
06:36 Today Wedbush
DocuSign downgraded to Neutral from Outperform at Wedbush
06:36 Today JMP Securities
DocuSign price target lowered to $307 from $320 at JMP Securities
06:17 Today Citi
DocuSign price target lowered to $231 from $389 at Citi
DOCU DocuSign
/

+

DOCU DocuSign
/

+

DOCU DocuSign
/

+

DOCU DocuSign
/

+

Recommendations
Corvus Pharmaceuticals price target raised to $8 from $5 at Cantor Fitzgerald » 07:18
12/03/21
12/03
07:18
12/03/21
07:18
CRVS

Corvus Pharmaceuticals

$3.31 /

+0.05 (+1.53%)

, AZN

AstraZeneca

$54.78 /

-0.1 (-0.18%)

Cantor Fitzgerald analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CRVS Corvus Pharmaceuticals
$3.31 /

+0.05 (+1.53%)

AZN AstraZeneca
$54.78 /

-0.1 (-0.18%)

CRVS Corvus Pharmaceuticals
$3.31 /

+0.05 (+1.53%)

12/01/21 Jefferies
Corvus Pharmaceuticals initiated with a Buy at Jefferies
09/22/21 Roth Capital
Corvus recent rally due to AstraZeneca data, says Roth Capital
08/03/21 Cantor Fitzgerald
Corvus Pharmaceuticals price target lowered to $5 from $10 at Cantor Fitzgerald
08/03/21 Mizuho
Corvus Pharmaceuticals price target lowered to $3.50 from $4 at Mizuho
AZN AstraZeneca
$54.78 /

-0.1 (-0.18%)

11/29/21 Morgan Stanley
AstraZeneca price target raised to 10,200 GBp from 10,000 GBp at Morgan Stanley
11/22/21 Bryan Garnier
AstraZeneca downgraded to Buy from Conviction Buy at Bryan Garnier
10/27/21 SVB Leerink
Seagen price target raised to $200 from $190 at SVB Leerink
10/19/21 UBS
AstraZeneca price target raised to 10,000 GBp from 9,200 GBp at UBS
CRVS Corvus Pharmaceuticals
$3.31 /

+0.05 (+1.53%)

AZN AstraZeneca
$54.78 /

-0.1 (-0.18%)

  • 12
    Feb
AZN AstraZeneca
$54.78 /

-0.1 (-0.18%)

CRVS Corvus Pharmaceuticals
$3.31 /

+0.05 (+1.53%)

AZN AstraZeneca
$54.78 /

-0.1 (-0.18%)

CRVS Corvus Pharmaceuticals
$3.31 /

+0.05 (+1.53%)

AZN AstraZeneca
$54.78 /

-0.1 (-0.18%)

Upgrade
Citi upgrades Upstart to Buy on resumption after 55% selloff » 07:18
12/03/21
12/03
07:18
12/03/21
07:18
UPST

Upstart

$176.65 /

-3.1 (-1.72%)

Citi analyst Peter…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
UPST Upstart
$176.65 /

-3.1 (-1.72%)

UPST Upstart
$176.65 /

-3.1 (-1.72%)

07:05 Today Citi
Upstart upgraded to Buy from Neutral at Citi
11/10/21 Piper Sandler
Upstart should be bought on earnings selloff, says Piper Sandler
10/26/21
Fly Intel: Top five analyst downgrades
10/26/21 Jefferies
Jefferies downgrades Upstart to Hold, doubles target to $330
UPST Upstart
$176.65 /

-3.1 (-1.72%)

  • 16
    Jun
  • 09
    Apr
  • 16
    Dec
UPST Upstart
$176.65 /

-3.1 (-1.72%)

UPST Upstart
$176.65 /

-3.1 (-1.72%)

Hot Stocks
Hagerty to begin trading on NYSE on December 3 » 07:17
12/03/21
12/03
07:17
12/03/21
07:17
HGTY

Hagerty

$10.89 /

+0.735 (+7.24%)

, ADF

Aldel Financial

/

+

Hagerty (HGTY) announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HGTY Hagerty
$10.89 /

+0.735 (+7.24%)

ADF Aldel Financial
/

+

Recommendations
Marvell price target raised to $98 from $85 at BMO Capital » 07:14
12/03/21
12/03
07:14
12/03/21
07:14
MRVL

Marvell

$71.02 /

+0.18 (+0.25%)

BMO Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MRVL Marvell
$71.02 /

+0.18 (+0.25%)

MRVL Marvell
$71.02 /

+0.18 (+0.25%)

07:10 Today Goldman Sachs
Goldman admits to being wrong to stay on sidelines, upgrades Marvell to Buy
07:06 Today Goldman Sachs
Marvell upgraded to Buy from Neutral at Goldman Sachs
06:49 Today UBS
Marvell price target raised to $95 from $87 at UBS
06:38 Today Credit Suisse
Marvell price target raised to $105 from $85 at Credit Suisse
MRVL Marvell
$71.02 /

+0.18 (+0.25%)

MRVL Marvell
$71.02 /

+0.18 (+0.25%)

MRVL Marvell
$71.02 /

+0.18 (+0.25%)

MRVL Marvell
$71.02 /

+0.18 (+0.25%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.